Statistics on Biotechnology Use Business Sector Biotechnology indicators by branch of activity. Unidades: Specified in each variable Total companies Services Industry and Construction Agriculture Number of companies carrying out R&D in Biotechnology 1.444 107 455 883 % Companies by type of biotechnology used: Genetic Code 30,7 21,5 16,8 38,9 % Companies by type of biotechnology used: Functional Units 37,6 18,7 33,2 42,1 % Companies by type of biotechnology used: Cell and Tissue Culture and Engineering 21,3 15,6 15,1 25,2 % Companies by type of biotechnology used: Bioprocesses 50,9 47,5 75,7 38,6 % Companies by type of biotechnology used: Subcellular Organisms 8,1 0,9 6,6 9,7 % Companies by type of biotechnology used: Bioinformatics 22,6 4,7 10,2 31,2 % Companies by type of biotechnology used: Nanobiotechnology 9,8 0,9 5,1 13,3 % Companies by type of biotechnology used: Other 16,9 29,6 9,8 19 Companies in which biotechnology activities are: Main and/or exclusive 629 20 111 498 Companies in which biotechnology activities are: A secondary business line 262 17 100 145 Companies in which biotechnology activities are: A necessary tool for production 553 70 243 240 % Companies by final application areas of biotechnology use: Human Health 44,3 1,9 24,5 59,6 % Companies by final application areas of biotechnology use: Animal Health and Aquaculture 15,8 17,9 13,2 16,9 % Companies by final application areas of biotechnology use: Food Products 30,7 30,9 48,3 21,6 % Companies by final application areas of biotechnology use: Agriculture and Forestry 24,9 65,7 22,2 21,4 % Companies by final application areas of biotechnology use: Environment 16,9 13,2 17,2 17,2 % Companies by final application areas of biotechnology use: Industry 12,6 6,3 13 13,1 R&D personnel in Biotechnology (PP) 17.743 1.000 5.585 11.158 R&D personnel in Biotechnology (PP): Research personnel 9.445 293 2.218 6.934 R&D personnel in Biotechnology (PP): Technical and auxiliary personnel 8.298 708 3.367 4.224 R&D personnel in Biotechnology (PP). Women 9.907 356 3.102 6.449 R&D personnel in Biotechnology (PP). Women: Research personnel 5.104 113 1.155 3.836 R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel 4.802 243 1.946 2.613 R&D personnel in Biotechnology (FTE) 12.993,4 616,8 3.924,1 8.452,5 R&D personnel in Biotechnology (FTE): Research personnel 7.069,9 194,7 1.616 5.259,3 R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel 5.923,6 422,1 2.308,1 3.193,3 R&D personnel in Biotechnology (FTE). Women 7.471,8 223,8 2.336,7 4.911,2 R&D personnel in Biotechnology (FTE). Women: Research personnel 3.870,1 73,4 894 2.902,8 R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel 3.601,6 150,5 1.442,8 2.008,4 Expenditure on internal R&D in Biotechnology (thousands of euros) 1.223.801 36.807 437.823 749.171 1) By type of expenditure: Current expenditure 1.108.189 33.108 406.903 668.179 1.1) Labour expenditure of research personnel 360.922 9.392 108.070 243.460 1.2) Labour expenditure of technical and auxiliary personnel 220.540 11.866 91.401 117.272 1.3) Other current expenditure 526.727 11.849 207.432 307.446 2) By type of expenditure: Capital expenditure 115.612 3.699 30.921 80.993 2.1) Land and buildings 16.843 1.812 2.957 12.074 2.2) Equipment and tools 63.527 1.809 22.909 38.809 2.3) Acquisition of specific R&D software 3.959 61 841 3.057 2.4) Other R&D-specific IP products 31.284 17 4.214 27.054 1.1) By origin of funds: Own funds 860.603 34.837 371.804 453.963 1.2) By origin of funds: Funds from the Business sector 128.002 84 5.242 122.675 1.3) By origin of funds: Funds from the Public Administration sector 119.498 1.832 17.353 100.313 1.4) By origin of funds: Funds from the Higher Education sector 647 0 9 638 1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector 12.986 0 19 12.966 1.6) By origin of funds: Funds from the rest of the world 102.065 54 43.395 58.617 Purchase of R&D services (external R&D) in Biotechnology (thousands of euros) 123.396 775 74.871 47.750 Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain 88.985 775 63.502 24.707 Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world 34.412 0 11.368 23.043 % Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital 39,8 31,1 28,2 46,8 % Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information 15,3 15,3 18,5 13,6 % Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources 22,3 24,6 20,8 22,8 % Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain 12,1 8,1 11,5 12,9 % Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets 17,1 8,1 12,2 20,7 % Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels 17,8 11 14,6 20,3 % Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception 16 14,9 16,5 15,8 % Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements 41,4 49 39,6 41,5 % Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost 50,2 51,3 50,5 50 % Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting 20,1 25,4 17,2 20,9 % Companies with international revenues related to biotechnology activities 22,7 8,1 22,3 24,7 % Companies representing international revenues related to biotechnology activities 2,1 4,6 1,9 3,5 % International revenues related to biotechnology activities distributed in: Revenues from the EU 60,6 88,4 63 46,9 % International revenues related to biotechnology activities distributed in: Revenues from the rest of the world 39,4 11,6 37 53,1 % International revenues related to biotechnology activities by classification: International trade in goods and services 87,8 100 88,6 82,7 % International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 10,1 0 10,7 8,8 % International revenues related to biotechnology activities by classification: Subsidies from external sources 1,4 0 0,6 4,9 % International revenues related to biotechnology activities by classification: Other 0,8 0 0,1 3,6 Notas: Data referring to all companies that carry out internal R&D in Biotechnology. 2) ' .'= numeric data equal to zero not resulting from rounding 3) FTE: Full-Time Equivalence Fuente: National Statistics Institute